ArticleCureus2025
A Retrospective Study on the Prevalence of Hepatitis A Virus in Patients With Acute Viral Hepatitis at a Tertiary Care Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Seroprevalence of IgG antibodies against hepatitis-A infection among individuals aged 6-30 years in India, 2021: a nationwide population-based cross-sectional study.The Lancet regional health. Southeast Asia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis A virus (HAV) is a common cause of acute viral hepatitis, especially in developing countries. HAV poses a major public health problem in India. A retrospective study was carried out to ascertain the prevalence, demographic characteristics, and clinical outcomes of the hepatitis A virus in patients who presented with acute viral hepatitis at a tertiary care hospital between November 2022 and October 2024. About 656 samples were included in this study; 142 of the 656 samples tested positive for HAV IgM enzyme-linked immunosorbent assay (ELISA). In July and August of 2023, there was a sharp increase in seropositive cases linked to person-to-person transmission. In this study, the overall prevalence was 22%. The most frequent symptoms were fever, followed by stomach pain and yellowish urine. The hepatitis A virus primarily affects young children and a small percentage of adults and adolescents from lower and intermediate socioeconomic backgrounds who drink subterranean water. The seroprevalence of the hepatitis A virus is influenced by time and geographic spread. When caring for children under two, the most important preventative measure is to wash your hands properly. The current study also emphasizes the necessity of planning decisions on public health policies, such as vaccination plans, safe drinking water sources, and sanitation programs, in order to better control the hepatitis A virus and ensure its appropriate usage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.